Synapse - Works

Results (13087)

Rapid reduction of peripheral blasts in older patients with refractory acute myeloid leukemia (AML) using re-induction with single agent anti-CD45 targeted iodine ((131)I) apamistamab [Iomab-B] radioimmunotherapy in the phase III SIERRA trial

Meeting Abstract

Tomlinson, B. K.; Reddy, V.; Berger, M. S.; Spross, J.; Lichtenstein, R.; Gyurkocza, B.
Clinical Lymphoma, Myeloma and Leukemia (2019)

Fulltext@MSK | Save

Ivosidenib (IVO; AG-120) in IDH1-mutant newly-diagnosed acute myeloid lukemia (ND AML): Updated results from a phase 1 study

Meeting Abstract

DiNardo, C. D.; Roboz, G. J.; Stein, E. M.; de Botton, S.; Mims, A. S.; Prince, G. T.; Altman, J. K.; Arellano, M. L.; Donnellan, W.; Erba, H. P.; more...
Clinical Lymphoma, Myeloma and Leukemia (2019)

Fulltext@MSK | Save

Setting up a CAR T program ins and outs

Meeting Abstract

Giralt, S.
Clinical Lymphoma, Myeloma and Leukemia (2019)

Fulltext@MSK | Save

Who is a candidate for watch and wait therapy in mantle cell lymphoma?

Meeting Abstract

Kumar, A.
Clinical Lymphoma, Myeloma and Leukemia (2019)

Fulltext@MSK | Save

Mutant IDH1 inhibitor ivosidenib (IVO; AG-120) in combination with azacitidine (AZA) for newly diagnosed acute myeloid leukemia (ND AML)

Meeting Abstract

DiNardo, C. D.; Stein, A. S.; Stein, E. M.; Fathi, A. T.; Frankfurt, O.; Schuh, A. C.; Döhner, H.; Martinelli, G.; Raffoux, E.; Tan, P.; more...
Clinical Lymphoma, Myeloma and Leukemia (2019)

Fulltext@MSK | Save

Post-treatment ANC is predictive of poorer overall survival and disease-free survival in esophageal cancer patients after tri-modality therapy

Meeting Abstract

Zhang, M.; Jackson, A.; Montovano, M.; Ku, G.; Janjigian, Y.; Ilson, D. H.; Yorke, E. D.; Crane, C. H.; Wu, A. J.
International Journal of Radiation Oncology, Biology, Physics (2019)

Fulltext@MSK | Save

Genetic determinants of chemoradiation response and survival in locally advanced esophageal carcinoma treated with trimodality therapy

Meeting Abstract

Pitter, K. L.; Casey, D. L.; Oh, P.; Setton, J.; Ku, G.; Ilson, D. H.; Janjigian, Y.; Bains, M. S.; Jones, D.; Molena, D.; more...
International Journal of Radiation Oncology, Biology, Physics (2019)

Fulltext@MSK | Save

CCR4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders and its implications for diagnosis and treatment

Meeting Abstract

Geller, S.; Hollmann, T. J.; Horwitz, S. M.; Myskowski, P. L.; Pulitzer, M.
Journal of Investigative Dermatology (2019)

Fulltext@MSK | Save

PICALM-MLLT10 fusion commonly presents with extramedullary acute leukemia and often with a mixed phenotype (MPAL)

Meeting Abstract

Tashkandi, H.; Xiao, W.; Roshal, M.; Zhang, Y.; Arcila, M.; Benayed, R.; Sen, F.; Ho, C.; Baik, J.; Pichardo, J.; more...
Modern Pathology (2019)

Fulltext@MSK | Save

Plasma cell immunophenotypic abnormalities as predictors of progression in patients with monoclonal gammopathy of undetermined significance and smoldering plasma cell myeloma

Meeting Abstract

Galera, P.; Sun, X.; Yuan, C.; Stetler-Stevenson, M.; Landgren, O.; Kazandjian, D.; Maric, I.
Modern Pathology (2019)

Fulltext@MSK | Save